Lectin enhancement of the lipofection efficiency in human lung carcinoma cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1472, Issue 1-2, 1999, Pages 25-33

  Yanagihara, Katsunori ^a   Cheng, Pi Wan ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Gene therapy; Gene transfer; Lectin; Liposome; Non viral vector

Indexed keywords

BETA GALACTOSIDASE; LECTIN; PLASMID DNA;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; REPORTER GENE;

HUMANS; LECTINS; LIPOSOMES; LUNG NEOPLASMS; METHYLGALACTOSIDES; PLANT LECTINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032883606     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00100-2     Document Type: Article

References (31)

1. Boring C.C., Squires T.S., Tong T. Cancer statistics. Ca Cancer J. Clin. 44:1994;7-26.
2. V.E. Gould, W.H. Warren, Epithelial neoplasm of the lung, in: Thoracic Oncology, Saunders, Philadelphia, PA, 1989, pp. 77-93.
3. Belani C.P. Multimodality management of regionally advanced non-small cell cancer. Semin. Oncol. 20:1993;302-314.
4. Roth J.A., Fossella F., Komaki R., Ryan M.B., Putnam J.B. Jr., Dhingra H., De Caro L., Chasen M., McGarvran M. A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage 3A non-small-cell lung cancer. J. Natl. Cancer Inst. 86:1994;673-680.
5. Fang K., Chen M.H. Transfection of anti-sense complementary DNA of human epidermal-growth-factor receptor attenuates the proliferation of human non-small-cell-lung-cancer cells. Int. J. Cancer. 81:1999;471-478.
6. Kauczor H.U., Schuler M., Heussel C.P., von Weymarn A., Bongartz G., Rochlitz C., Huber C., Thelen M. CT-guided intratumoral gene therapy in non-small-cell lung cancer. Eur. Radiol. 9:1999;292-296.
7. Hay J.G., Shapiro N., Sauthoff H., Heitner S., Phupakdi W., Rom W.N. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55KD gene. Hum. Gene Ther. 10:1999;479-590.
8. Nikitin A.Y., Juarez-Perez M.I., Li S., Huang L., Lee W.-H. RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. Proc. Natl. Acad. Sci. USA. 96:1999;3916-3921.
9. Colledge W.H. Cystic fibrosis gene therapy. Curr. Opin. Gene Dev. 4:1994;466-471.
10. Olsen J.C., Huang W., Johnson L.G., Boucher R.C. Persistence adenoviral vector gene expression in CF airway cells is due to integration of vector sequences into chromosomal DNA. Pediatr. Pulmonol. S10:1994;230.
11. Cotton M., Wagner E. Non-viral approaches to gene therapy. Curr. Opin. Biotechnol. 4:1993;705-710.
12. Ledley F.D. Non-viral gene therapy. Curr. Opin. Biotechnol. 5:1994;626-636.
13. Yei S., Mittereder N., Tang K., O'Sullivan C., Trapnell B.C. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1:1991;192-200.
14. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., Wilson J.M. Cellular immunity to viral antigen limits E1-deleted adenovirus for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407-4411.
15. Morgan J.R., Tompkins R.G., Yarmush M.L. Advances in recombinant retroviruses for gene delivery. Adv. Drug Deliv. Rev. 12:1993;143-158.
16. Trapnell B.C., Gorziglia M. Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5:1994;617-625.
17. Ponnazhagan S., Erikson D., Kearns W.G., Zhou S.Z., Nahreini P., Wang X.S., Srivastava A. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomics in humapton cell. Hum. Gene Ther. 8:1994;275.
18. Fairbairn L.J., Cross M.A., Arrand J.R. Paterson Symposium 1993 - Gene therapy. Br. J. Cancer. 159:1994;972-975.
19. Russel D.W., Miller A.D., Alexander I.E. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA. 91:1994;8915-8919.
20. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262:1987;4429-4432.
21. Yin W., Cheng P.-W. Lectin conjugate-directed gene transfer to airway epithelial cells. Biochem. Biophys. Res. Commun. 205:1994;826-833.
22. Felgner J.H., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
23. Cheng P.-W. Receptor ligand gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum. Gene Ther. 7:1996;275-282.
24. Cheng P.-W., Johnson L. Restoration of chloride transport properties of CFT1 cells by insulin-facilitated gene transfer. Am. J. Respir. Crit. Care Med. 153:1996;A114.
25. Xu L., Pirollo K.F., Chang E.H. Transferrin-liposome-mediated p53 sensitization of a squamous cell carcinoma of the head and neck to radiation in vitro. Hum. Gene Ther. 8:1997;467-475.
26. K. Yanagihara, H. Cheng, P.-W. Cheng, Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cells, Cancer Gene Ther. 6 (1999) in press.
27. M.E. Greenberg, T.P. Bender, Identification of newly transcribed RNA, Current Protocols in Molecular Biology, John Wiley and Sons, Boston, MA, 1997, 4.10.2.
28. Batra R.K., Wang-Johanning F., Wagner E., Garver R.I. Jr., Curiel D.T. Receptor-mediated gene delivery employing lectin-binding specificity. Gene Ther. 1:1994;255-260.
29. Gillilard D.G., Collier R.J., Moehring J.M., Moehring T.J. Chimeric toxins: toxic, disulfide-linked conjugate of concanavalin A with fragment A from diphtheria toxin. Proc. Natl. Acad. Sci. USA. 75:1978;5319-5323.
30. Lin J.-Y., Li J.-S., Tung T.-C. Lectin derivatives of methotrexate and chlorambucil as chemotherapeutic agents. J. Natl. Cancer Inst. 66:1981;523-528.
31. Albelta S.M., Buck C.A. Integrin and other cell adhesion molecules. FASEB J. 4:1990;2868-2880.